McAleenan, A., Howell, A., Kernohan, A., Faulkner, C. L., Dawson, S., Wragg, C., . . . Kurian, K. M. (2019). Prognostic value of test(s) for O(6)‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide. Cochrane Database Syst Rev.
Citação norma ChicagoMcAleenan, Alexandra, et al. "Prognostic Value of Test(s) for O(6)‐methylguanine–DNA Methyltransferase (MGMT) Promoter Methylation for Predicting Overall Survival in People With Glioblastoma Treated With Temozolomide." Cochrane Database Syst Rev 2019.
Citação norma MLAMcAleenan, Alexandra, et al. "Prognostic Value of Test(s) for O(6)‐methylguanine–DNA Methyltransferase (MGMT) Promoter Methylation for Predicting Overall Survival in People With Glioblastoma Treated With Temozolomide." Cochrane Database Syst Rev 2019.